Omnicell, Inc. (Nasdaq: OMCL) announced the commencement of the STOMPP (Study the Effect of a Hybrid Pharmacy Practice Model on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE